Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

2nd Nov 2015 10:38

RNS Number : 1827E
Source BioScience PLC
02 November 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

SOURCE BIOSCIENCE PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation: iii

 

Harwood Capital LLP (as investment adviser/manager) and North Atlantic Smaller Companies Investment Trust plc

4. Full name of shareholder(s)

(if different from 3.): iv

 

1. NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

2. ORYX INTERNATIONAL GROWTH FUND LIMITED

 

 

5. Date of the transaction and date on which the threshold is crossed or reached: v

29 OCTOBER 2015

6. Date on which issuer notified:

30 OCTOBER 2015

7. Threshold(s) that is/are crossed or

reached: vi, vii

 

 

Total Holding through 15%

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

HOLDER 1

 

HOLDER 2

 

 1,500,000

 

50,000,000

 

1,500,000

 

50,000,000

 

2,750,000

 

50,000,000

 

 2,750,000

 

50,000,000

 

 

0.79%

 

14.32%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,750,000

15.11%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

14. Contact name:

Jane Muir

15. Contact telephone number:

020 8819 6486

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGGAWGUPAGUP

Related Shares:

North Atl.smlrSBS.L
FTSE 100 Latest
Value8,809.74
Change53.53